Review
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jul 15, 2019; 10(7): 376-395
Published online Jul 15, 2019. doi: 10.4239/wjd.v10.i7.376
Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes
Yulia A Nasykhova, Yury A Barbitoff, Elena A Serebryakova, Dmitry S Katserov, Andrey S Glotov
Yulia A Nasykhova, Yury A Barbitoff, Andrey S Glotov, Laboratory of Biobanking and Genomic Medicine of Institute of Translation Biomedicine, St. Petersburg State University, St. Petersburg 199034, Russia
Yulia A Nasykhova, Elena A Serebryakova, Andrey S Glotov, Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproductology, St. Petersburg 199034, Russia
Yury A Barbitoff, Bioinformatics Institute, St. Petersburg 194021, Russia
Yury A Barbitoff, Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg 199034, Russia
Elena A Serebryakova, Andrey S Glotov, Department of Genetics, City Hospital No. 40, St. Petersburg 197706, Russia
Dmitry S Katserov, Andrey S Glotov, Institute of Living Systems, Immanuel Kant Baltic Federal University, Kaliningrad 236016, Russia
Author contributions: All authors contributed equally to the work.
Supported by D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproductology, project 558-2019-0012 (АААА-А19-119021290033-1) of FSBSI.
Conflict-of-interest statement: No potential conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Andrey S Glotov, DSc, PhD, Head of Department, Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproductology, Mendeleevskaya Line 3, St. Petersburg 199034, Russia. anglotov@mail.ru
Telephone: +7-911-7832003 Fax: +7-812-3280262
Received: February 21, 2019
Peer-review started: February 22, 2019
First decision: May 8, 2019
Revised: May 23, 2019
Accepted: June 11, 2019
Article in press: June 11, 2019
Published online: July 15, 2019
Core Tip

Core tip: Next-generation sequencing (NGS) technologies have a broad range of applications in studying the genetic causes of type 2 diabetes (T2D), such as: (1) Identification of rare and common genetic variants, associated with disease; (2) Functional studies for describing role of genes in disease pathogenesis; and (3) Evaluation of environmental contribution to the disease by using microbiome profiling methods. This review of NGS application to the genetic research of T2D presents the advances and challenges related with sequencing analysis-based studies and implementation of this knowledge in clinical practice.